Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
2020 · Nature Medicine · 537 citations
https://doi.org/10.1038/s41591-020-0998-x
P
Pavlo Gilchuk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
9.3K
Citations
40
h-index
68
i10-index
Pavlo Gilchuk is an academic researcher from AstraZeneca (Japan). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Viral Infections and Outbreaks Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 40, co-authored 96 publications.
ORCID: 0000-0002-3212-007XPapers by this author
worksGenetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
2021 · Nature Microbiology · 325 citations
https://doi.org/10.1038/s41564-021-00972-2
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections
2016 · Cell · 260 citations
https://doi.org/10.1016/j.cell.2016.09.049
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
2021 · Cell Reports · 149 citations
https://doi.org/10.1016/j.celrep.2021.109364
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
2021 · Cell Reports · 110 citations
https://doi.org/10.1016/j.celrep.2021.109604
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
2021 · Immunity · 105 citations
https://doi.org/10.1016/j.immuni.2021.08.016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat